150 related articles for article (PubMed ID: 16140485)
1. Targeting primaquine into liver using chylomicron emulsions for potential vivax malaria therapy.
Dierling AM; Cui Z
Int J Pharm; 2005 Oct; 303(1-2):143-52. PubMed ID: 16140485
[TBL] [Abstract][Full Text] [Related]
2. Formulation, antimalarial activity and biodistribution of oral lipid nanoemulsion of primaquine.
Singh KK; Vingkar SK
Int J Pharm; 2008 Jan; 347(1-2):136-43. PubMed ID: 17709216
[TBL] [Abstract][Full Text] [Related]
3. Gadolinium incorporated reconstituted chylomicron emulsion for potential application in tumor neutron capture therapy.
Dierling AM; Sloat BR; Cui Z
Eur J Pharm Biopharm; 2006 Apr; 62(3):275-81. PubMed ID: 16274979
[TBL] [Abstract][Full Text] [Related]
4. Toxicological study of the primaquine phosphate loaded chitosan nanoparticles in mice.
Rajera R; Nagpal K; Singh SK; Mishra DN
Int J Biol Macromol; 2013 Nov; 62():18-24. PubMed ID: 23973494
[TBL] [Abstract][Full Text] [Related]
5. [Plasmodium vivax malaria: treatment of primary attacks with primaquine, in three different doses, and a fixed dose of chloroquine, Antioquia, Colombia, 2003-2004].
Carmona-Fonseca J; Alvarez G
Biomedica; 2006 Sep; 26(3):353-65. PubMed ID: 17175999
[TBL] [Abstract][Full Text] [Related]
6. Methemoglobinemia and adverse events in Plasmodium vivax malaria patients associated with high doses of primaquine treatment.
Carmona-Fonseca J; Alvarez G; Maestre A
Am J Trop Med Hyg; 2009 Feb; 80(2):188-93. PubMed ID: 19190211
[TBL] [Abstract][Full Text] [Related]
7. [A preliminary study on the inhibitory action of target-primaqine on the exoerythrocytic forms of Plasmodium yoelii yoelii].
Song J; Wang X; Huang F; Feng C; Zhang Z; Huo Y; Pang Q
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1995; 13(2):117-9. PubMed ID: 7554159
[TBL] [Abstract][Full Text] [Related]
8. [Study of pharmacokinetics of liver targeting antimalarial agent neoglycoalbumin-primaquine conjugate (NGA-PQ) and primaquine phosphate in mouse].
Li TL; Pang QJ; He YL; Wang P
Yao Xue Xue Bao; 1995; 30(10):721-5. PubMed ID: 8701725
[TBL] [Abstract][Full Text] [Related]
9. Effect of primaquine standard dose (15 mg/day for 14 days) in the treatment of vivax malaria patients in Thailand.
Buchachart K; Krudsood S; Singhasivanon P; Treeprasertsuk S; Phophak N; Srivilairit S; Chalermrut K; Rattanapong Y; Supeeranuntha L; Wilairatana P; Brittenham G; Looareesuwan S
Southeast Asian J Trop Med Public Health; 2001 Dec; 32(4):720-6. PubMed ID: 12041544
[TBL] [Abstract][Full Text] [Related]
10. Vivax malaria: preliminary observations following a shorter course of treatment with artesunate plus primaquine.
Dao NV; Cuong BT; Ngoa ND; Thuy le TT; The ND; Duy DN; Dai B; Thanh NX; Chavchich M; Rieckmann KH; Edstein MD
Trans R Soc Trop Med Hyg; 2007 Jun; 101(6):534-9. PubMed ID: 17368694
[TBL] [Abstract][Full Text] [Related]
11. Enantioselective metabolism of primaquine by human CYP2D6.
Fasinu PS; Tekwani BL; Nanayakkara NP; Avula B; Herath HM; Wang YH; Adelli VR; Elsohly MA; Khan SI; Khan IA; Pybus BS; Marcsisin SR; Reichard GA; McChesney JD; Walker LA
Malar J; 2014 Dec; 13():507. PubMed ID: 25518709
[TBL] [Abstract][Full Text] [Related]
12. Biochemically altered human erythrocytes as a carrier for targeted delivery of primaquine: an in vitro study.
Alanazi FK; Harisa Gel-D; Maqboul A; Abdel-Hamid M; Neau SH; Alsarra IA
Arch Pharm Res; 2011 Apr; 34(4):563-71. PubMed ID: 21544721
[TBL] [Abstract][Full Text] [Related]
13. The conversion of primaquine into primaquine-aldehyde, primaquine-alcohol, and carboxyprimaquine, a major plasma metabolite.
Frischer H; Mellovitz RL; Ahmad T; Nora MV
J Lab Clin Med; 1991 Jun; 117(6):468-76. PubMed ID: 2045714
[TBL] [Abstract][Full Text] [Related]
14. Profiling primaquine metabolites in primary human hepatocytes using UHPLC-QTOF-MS with 13C stable isotope labeling.
Avula B; Tekwani BL; Chaurasiya ND; Nanayakkara NP; Wang YH; Khan SI; Adelli VR; Sahu R; Elsohly MA; McChesney JD; Khan IA; Walker LA
J Mass Spectrom; 2013 Feb; 48(2):276-85. PubMed ID: 23378100
[TBL] [Abstract][Full Text] [Related]
15. Management of vivax malaria with primaquine.
Beeching NJ; Lalloo DG; Bannister BA
J Infect; 2007 Sep; 55(3):282. PubMed ID: 17604840
[No Abstract] [Full Text] [Related]
16. Preparation, characterization, and optimization of primaquine-loaded solid lipid nanoparticles.
Omwoyo WN; Ogutu B; Oloo F; Swai H; Kalombo L; Melariri P; Mahanga GM; Gathirwa JW
Int J Nanomedicine; 2014; 9():3865-74. PubMed ID: 25143734
[TBL] [Abstract][Full Text] [Related]
17. Galactose-Anchored Gelatin Nanoparticles for Primaquine Delivery and Improved Pharmacokinetics: A Biodegradable and Safe Approach for Effective Antiplasmodial Activity against P. falciparum 3D7 and in Vivo Hepatocyte Targeting.
Kumar H; Gothwal A; Khan I; Nakhate KT; Alexander A; Ajazuddin ; Singh V; Gupta U
Mol Pharm; 2017 Oct; 14(10):3356-3369. PubMed ID: 28836792
[TBL] [Abstract][Full Text] [Related]
18. [Effect of daphnetin on the exo-erythrocytic stage of rodent malaria].
Liu YG; Wang QM; Xu YQ; Ni QZ; Ni YC
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2001; 19(1):30-2. PubMed ID: 12572020
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and pharmacodynamics of (+)-primaquine and (-)-primaquine enantiomers in rhesus macaques (Macaca mulatta).
Saunders D; Vanachayangkul P; Imerbsin R; Khemawoot P; Siripokasupkul R; Tekwani BL; Sampath A; Nanayakkara NP; Ohrt C; Lanteri C; Gettyacamin M; Teja-Isavadharm P; Walker L
Antimicrob Agents Chemother; 2014 Dec; 58(12):7283-91. PubMed ID: 25267666
[TBL] [Abstract][Full Text] [Related]
20. A nanochitosan-D-galactose formulation increases the accumulation of primaquine in the liver.
Gomes F; Ribeiro AC; Sanches GS; Borges HS; Takahashi LAU; Daniel-Ribeiro CT; Tedesco AC; Nascimento JWL; Carvalho LJM
Antimicrob Agents Chemother; 2024 May; 68(5):e0091523. PubMed ID: 38517190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
